CellRapeutics™ Leukopak from Hepatitis C Donor (XS-0426-XU243)

Name: CellRapeutics™ Leukopak from Hepatitis C Donor
SKU: XS-0426-XU243
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This Leukopak is harvested from donors with a history of Hepatitis C Virus infection, providing a cellular snapshot of the systemic response to this highly mutable RNA virus. The collection is rich in memory T-cell subsets and reflects the chronic B-cell stimulation often associated with HCV-related mixed cryoglobulinemia. It is an ideal substrate for studying viral-induced lymphoproliferative disorders and the long-term immune recovery following Direct-Acting Antiviral therapy.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Hepatitis C Donor

Cat. No.
XS-0426-XU243

Donor Age
Middle-Aged, Senior

Donor Health
Confirmed HCV infection. Leukocytes reflect a systemic response to chronic flaviviral infection, showing alterations in innate immune sensing and specific anti-HCV cellular memory.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose, optimized to maintain the integrity of viral-specific CD8⁺ T cells and innate lymphoid cells.

Additional Donor Information
Each lot features a Leukopak from donors with a history of HCV infection. Profiles include genotype information and treatment status, providing a platform for studying immune reconstitution after viral clearance.

Clinical Profile
Infection phase, genotype, and history of Direct-Acting Antiviral therapy or sustained virologic response status.

Additional Information

Medication History
Available upon request. Documentation of Direct-Acting Antiviral therapy and records of Sustained Virologic Response status.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Hepatitis C Donor, Leukopak, Hepatitis C

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Hepatitis C Donor (XS-0426-XU243). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.